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Abstract
Digital healthcare promises to achieve cost-efficiency gains, improve clinical effectiveness, support better public
sector governance by enhancing transparency and accountability, and increase confidence in medical diagnoses,
especially in the field of oncology. This article aims to discuss the benefits offered by digital technologies in tax-
based European healthcare systems against the backdrop of structural bureaucratic rigidities and a slow pace of
implementation.
Artificial intelligence (AI) will transform the existing delivery of healthcare services, inducing a redesign of public
accountability systems and the traditional relationships between professionals and patients. Despite legitimate
ethical and accountability concerns, which call for clearer guidance and regulation, digital governance of healthcare
is a powerful means of empowering patients and improving their medical treatment in terms of quality and
effectiveness. On the path to better health, the use of digital technologies has moved beyond the back office of
administrative processes and procedures, and is now being applied to clinical activities and direct patient
engagement.
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Slow pace of digital health governance in Europe
In October of 2018, the Department of Health and So-
cial Care in the United Kingdom published a policy
paper on the future of digital data and technology, which
highlighted the widening gap between the implementa-
tion of digital healthcare and the original aspirations for
the service. It clearly stated, “the gap between where we
are and where we want to be is only getting bigger” [1].
In 2019, the Topol Review (prepared by the NHS)
reached similar conclusions and highlighted the divisive
nature of Artificial Intelligence (AI) within healthcare
[2]. The 2019 EU guidelines on the ethics of AI raised
concerns about the regulation of digital governance
among other trepidations [3]. It is widely accepted that
digital healthcare and AI will forever change the ways in
which healthcare is delivered to patients, as well as the
relationship between doctors and patients. There are
multiple objectives of digital health services: achieve cost
efficiency gains, improve the effectiveness of medical
treatments, boost the early diagnosis of illnesses, en-
hance surgeries with robotic systems, increase positive
healthcare outcomes, and help good governance of the
public sector by enhancing transparency and account-
ability [4].
This article aims to take stock of the opportunities of-
fered by digital technologies within the healthcare sector
against the backdrop of structural bureaucratic rigidities
and organizational resistance to embracing innovation.
Some have argued that AI has triggered a process of “in-
novative disruption”, because it will radically transform
the healthcare model from a business-to-business model
to a business-to-consumer model [5]. In these new sys-
tems, doctors will no longer be the bosses. In a recent
article, Richard Saltman discussed the impact of the
digital revolution (referring mainly to computer technol-
ogy) on the tax-funded healthcare systems of Europe.
His primary focus was on the future challenges and
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organizational constraints that will create obstacles to
the successful implementation of digital health govern-
ance [6]. He particularly emphasized the factors that de-
termine the slow progress of organizational innovation
when implementing digital technologies and new inte-
grated delivery arrangements within European tax-
funded healthcare systems. He criticized the
organizational stasis of public sector organizations,
which he labelled as a structural blockage, citing resist-
ance from public hospitals to organizational changes, in-
ternal reforms, and innovation. In regards to AI, the fear
is that robotic systems will replace doctors when it
comes to performing healthcare diagnoses. For instance,
retinal scans and targeted radiotherapy use AI systems
to carry out diagnoses with increasing confidence. Doc-
tors will need to be trained in data science and upgrade
their technology skills to be able to “control” these sys-
tems. However, the fear of job losses is exaggerated. In
fact, AI is likely to create new jobs, for instance, in the
field of machine learning and data science analysis.
The article by Richard Saltman pointed to the need for
more dynamic organizational change within public sec-
tor hospitals. Saltman also offered an insightful discus-
sion of some of the best practices of service delivery in
Europe and how they succeeded in overcoming the ten-
dencies towards inertia and ultimately embraced the
digital transformation of service delivery. We need to
take a step back and further elaborate on what “bureau-
cratic inertia” means in the context of European health-
care services. The issue of change in a bureaucratic
system is often framed in dysfunctional terms (see, for
instance, the term “disruption”), emphasising the traits
of public administration that lead inevitably to a patho-
logical state of institutional inefficiency and malaise, a
so-called “vicious cycle” in Crozier’s terms [7].
Saltman’s article poses the important question of dis-
tinguishing between “dynamic” and “stable” healthcare
systems, attributing to the former the capacity to
innovate and to the latter a sort of pathological immobi-
lisme. European tax funded systems belong to the latter
category. In many European healthcare systems, admin-
istrative and managerial change does not happen in big
and radical steps, and is only feasible through small, in-
cremental reforms that allow for institutional learning
and effective implementation [8]. Incrementalism is not
very different from inertial change, which refers to a uni-
form rate of motion done in a predictable series of incre-
ments [9]. This definition of inertia emphasises the
cumulative effect of incremental changes. Inertia is con-
ceptualised as a “force in motion”, which Richard Rose
describes as a “juggernaut”. Despite the legacy of past
decisions, incremental changes made by governments
can cumulatively produce big changes in the end [10].
Digital healthcare is likely to be adopted in incremental
steps within tax-funded European systems. On one hand,
technology keeps an eye on patients and is often in the
background of medical data and patient experiences. On
the other hand, AI is technically less developed and less
autonomous from human intelligence than we assume.
Further technological advances are needed to develop
“strong” systems of AI [11]. Furthermore, digital health-
care is increasingly subject to regulatory governance by
national and international bodies, while ethical concerns
are, for good or for worse, significantly slowing down
the pace of AI and other technologies.
The path to digital innovation: from information
technology (IT) to patients’ empowerment
through artificial intelligence (AI)
Technology, particularly digital technology, is increas-
ingly playing a key role in leveraging future health pol-
icies. In the last decade, national governments in Europe
have designed and implemented policies aimed at re-
structuring the delivery of healthcare services by using
new digital health infrastructures and services [12]. Elec-
tronic health records and patient data have been at the
core of this digitization process. Artificial Intelligence
(AI) requires medical health data, which is the most
valuable asset for AI producers and companies. Health-
care data is not merely a preference for marketing pur-
poses, but refers to symptoms, treatments, and patient
experiences. In fact, this term refers to highly sensitive
patient data protected by national legal systems and
regulations.
In the earlier stages on the path towards improved
digital healthcare, governments used ICT (Information
and Communication Technologies) to manage internal
administrative processes. The main purpose of
digitization was cost efficiency and improved effective-
ness of procedures. The administration of health units
has been using ICT for reimbursement procedures and
e-procurement, for instance. However, digitization in the
early days did not entail the participation of users and
patients in the process of service delivery.
More recently, e-health and e-government policies
have substantially redesigned the role of communication
with patients and their relatives [13]. These policies have
allowed for the development of more user-friendly, per-
sonalized services that rely on digital technologies, such
as the use of smartphone applications to monitor pa-
tients’ health conditions. On the path towards digital
governance, the use of digital technologies is now mov-
ing beyond the back office of administrative processes
and health data collection, and being consistently ap-
plied to direct service delivery and direct citizen engage-
ment. For instance, NHS Highland recently launched a
new programme that uses virtual reality to help patients
prepare for upcoming MRI scans in Scotland. This
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virtual device simulates the MRI experience for patients,
thus helping them be more comfortable during the pro-
cedure and making the MRI more bearable. This is just
one example of how AI improves the experience of
patients.
Our future challenge is not merely to introduce ICT
to public organizations, but also to reframe the trad-
itional relationship between professionals and patients
through the use of data sharing and digital technologies.
Thus, the changes affecting healthcare systems will be
transformative and not just marginal. The doctor-patient
relationship will change, which has given rise to legitim-
ate concerns. The empowerment of patients through
digital platforms has been adopted in order to promote
self-management of diseases and improve patients’ en-
gagement in the decision making process [14]. Digital
platforms allow patients and their families to have access
to a wealth of information about their conditions and to
connect more easily with professionals. The use of
digital platforms provides the tools for data-based
personalization of medicine and significantly increases
the focus on the customer and their specific needs [15].
However, as AI takes over low-level work, such as
monitoring heart rate or sleeping patterns, there are
concerns about the loss of human touch, which is so in-
tegral to the patient-doctor relationship. It is possible
that AI will serve as a gatekeeper and patients will inter-
act with a machine for low-level and routine practices.
Despite the possible costs of losing some human touch
for these services, AI will free up more time for doctors
to treat patients who need specialized care. For instance,
Ichilov Hospital in Tel Aviv, one of the largest hospitals
in Israel, launched a medical trial in September 2019 to
remotely monitor patients’ conditions using sensors and
cameras. The trial used an early detection instrument
for patients’ deteriorating conditions, which reduced the
nurses’ workload significantly. Ichilov Hospital collabo-
rated with two Israeli AI companies, which specialize in
monitoring systems (Innovision and BioBeat). In 2019,
the Israeli government launched a massive reform plan
to unleash AI technologies in healthcare organizations,
making use of the country’s advances in cyber security
technology.
In the field of oncology, digital healthcare has in-
creased the confidence of early stage diagnosis. For in-
stance, it provides quicker, better, and more cost-
efficient image analysis of prostate biopsies. Precision
medicine and new technologies promise to support doc-
tors in matching the immunoprofiles of patients using
targeted drugs for individual patients [16]. Robotic sys-
tems are used effectively and widely for complex surger-
ies. Another example of a widely used digital technology
is IBM’s Watson, an expert system developed by the
technological giant IBM. Watson is used as an instrument
for doctors to identify individualized, evidence-based
treatments. It collects a huge amount of medical data and
presents doctors with treatment options, then recom-
mends personalized drugs. The fees range from $200 to
$1000 USD per patient.
Hybrids and accountability
Saltman’s article does not discuss the benefits of digital
healthcare in terms of precision and personalized medi-
cine. Instead, the piece is more concerned with the
organizational impact of information technologies on
public sector providers and public hospitals. In his art-
icle, Saltman advocates greater structural diversity within
European NHS systems and better links with intermedi-
ate non-public providers and non-governmental actors.
This is a highly contested proposal for tax-funded Bever-
idge healthcare systems, for which public hospitals are
central elements of accountability for public health and
wellbeing [17]. Their institutional objectives depend on
equity and universal access-oriented efforts. The major-
ity of hospitals are still publicly owned and managed,
despite a wide range of managerial reforms and leader-
ship changes over the last few decades [18].
Major organizational changes began in the late 1980s
in Sweden and England, due to growing political pres-
sure on public authorities to restructure the hierarchal
governance models of healthcare providers [19]. Accord-
ing to Richards and Smith, new forms of hospital gov-
ernance pushed the state to focus on directing and
regulating rather than managing hospitals [20]. This
meant, for instance, the establishment of new public-
private partnerships between different stakeholders. In
these arrangements, the private sector is involved in de-
livering public goods and services and serves as a vehicle
for coordinating with non-governmental actors in order
to undertake integrated efforts to meet healthcare needs
[21]. The post-2008 economic crisis in Europe rein-
forced the shifting role of the state from rowing to steer-
ing [22]. As a result, we now have a diverse provider
environment within the European NHS systems, as well
as hybrid forms of accountability [23] and performance
measurement systems [24]. AI producers and developers
are for-profit businesses in many countries, which pro-
vide products and services to public sector organizations.
Traditional mechanisms of accountability need to adjust
to the new AI environment, which is characterized by
multiple stakeholders sharing medical data, research,
and systems.
The new digital environment for healthcare services re-
quires collaborative infrastructures and partnerships
across different stakeholders in the public, private, and
not-for-profit sectors. Hybrid forms of management have
emerged and will only continue to grow [25]. For instance,
data sharing agreements between different providers are
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central to AI systems. Hybrid accountability describes the
integration of accountability arrangements between and
across public, market, and social accountability regimes.
Hybrid forms of accountability layer and mix actors,
logics, norms, and mechanisms from public, market, and
social accountability regimes by concurrently applying two
or more of these differing regimes to the same situation
[26].
Ethical concerns and regulations
We need clearer guidance about the accountability of
AI, in order to foster an effective regulatory environment
that does not stifle innovation and govern hybrid forms
of arrangements without eschewing human agency and
oversight. This is probably the most critical concern as-
sociated with digital healthcare in the future. Regulation
is indeed necessary to protect patients’ safety, privacy,
and fundament rights and freedoms. As with the
pharmaceutical industry, AI developers should be regu-
lated by licensing and critical appraisal to remove unsafe
systems and procedures. A delicate balance needs to be
found between fostering innovation and regulating the
environment to implement AI in healthcare [27].
On the one hand, digital healthcare will disrupt the
existing delivery of healthcare services, enhancing a re-
design of internal organizational systems and procedures
for public accountability and transparency. For instance,
medical data storage associated with machine learning is
subject to new legal frameworks and risk assessment ob-
ligations, such as the data protection impact assessment
[28]. Hospitals and health organizations must revise in-
ternal procedures and design new employee training
programs to comply with European data privacy regula-
tions. Machine learning is particularly opaque, thus it is
highly difficult to ensure transparency about its use and
deployment. The EU ethical guidelines recommend that
AI systems should be identifiable and humans need to
be aware of the content of their interactions with ma-
chines. Furthermore, patients need to be able to under-
stand how AI systems work and how these technologies
can be applied to their conditions. Transparency and ac-
countability requirements are changing the governance
systems of health organizations.
NHS healthcare systems in Europe have adopted and
deployed artificial intelligence (AI), machine learning,
big data analytics, wearables, and other new technologies
to improve clinical accuracy, patient safety, precision
medicine, and personalized medicine. Yet, government
regulations may risk slowing down rapid developments
over concerns for accountability and the protection of
fundamental human rights. The EU is a frontrunner in
this policy area, as well as the ethical guidelines regard-
ing AI. The European Parliament has expressed many
concerns about the use of patients’ data and the security
of data generated through AI. In 2017, they initiated ac-
tions to legislate and regulate the new AI environment.
Digital healthcare certainly poses new challenges to ac-
countability arrangements that had previously been
based on a (human) principal and (human) agents. The
old arrangements of accountability will certainly be chal-
lenged by AI, given the ethical and philosophical impli-
cations associated with clinical choices and the ranking
of options, not made by humans. The EU guidelines rec-
ommend that clinical decisions rest in the hands of doc-
tors and that machines should be subject to human
oversight. Some scholars argue that a new concept of in-
formation accountability is necessary to manage these
processes [29].
For instance, what happens when IBM’s Watson for
Oncology (or other expert systems described earlier in
this article) is simply wrong? Legal frameworks associ-
ated with medical malpractice apply to people (the med-
ical professional or organization), but not machines.
Existing legal frameworks in many countries are not pre-
pared for sanctioning errors by machines that make mis-
takes whilst establishing a treatment ranking or
identifying drug prescriptions for individual patients.
Personhood is the legal basis for liability concerning
malpractice in both civil and tort law. What happens
when a machine makes an error that has detrimental
consequences for individual patients? Clearly a machine
cannot be in full control of itself. Thus, it is essential
that regulation provides for human oversight of these
technologies and that doctors remain in charge of clin-
ical decision-making.
The EU has promoted a “human centric-approach” to
AI that centrally focuses on the respect of fundamental
rights, including those set out in the Fundamental Rights
of the European Union. In April of 2019, the EU Commis-
sion drew up non-binding guidelines for AI design, devel-
opment, deployment, and implementation. The thrust of
this ethical approach is to protect human dignity and
agency throughout the use of these new technological sys-
tems by ensuring human control when interacting with
AI. Other ethical principles set out in the EU Commis-
sions’ guidelines are privacy and data protection to ensure
that citizens are always in full control of their own data.
Thus, AI systems in medical care should be designed with
techniques, such as data encryption and anonymisation to
protect patient data. Although the EU is a global frontrun-
ner in setting principles for the AI community (including
for giants such a Google, IBM, and Microsoft), the EU eth-
ics guidelines thus far are not legally binding and the regu-
latory oversights that support their implementation are
weak. A 2019 study by the European Parliament recom-
mends the creation of a regulatory body for algorithmic
decision-making, which will handle specific liability and
certification regimes [30].
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To conclude, tax-funded European healthcare systems
operate in a provider environment that is much more
organizationally diverse than it was 20 years ago. Part-
nership arrangements with non-governmental actors and
civil society are today an established governance model
in many countries. Hybrid organizational forms that mix
private and public delivery systems are the result of
waves of internal organizational restructuring [31]. AI
will consolidate the process of hybridization in health-
care governance. National governments in Europe and
the European Commission have embraced digital health-
care with enthusiasm, followed by legislative impetus
and regulatory frameworks that improve patients’ dig-
nity, transparency of governance processes, and enhance
patient engagement. The pace of change may still appear
slow to observers in other parts of the world, but one
should not be misguided by this slow rate of progress.
Major change is in the works, even though it is advan-
cing slowly. The pace of change is a result of the orienta-
tion of NHS healthcare systems towards values of equity,
universal access, and organizational values that are fun-
damentally different from those of privatized medicine.
Changes are incremental because of the desire to align
the population’s health needs with equity, efficiency, and
safety. Digital governance is widely accepted as the way
to achieve these objectives. The pace of change will re-
main uncertain because new hybrid accountability re-
gimes will need to be designed and AI will need to be
regulated at the national and European level. The out-
come will be a transformative change that will integrate
digital technologies into public sector modernization. AI
has great potential to empower patients, while improving
their health, personalized experiences, and individual
wellbeing.
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